• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

FDA panel votes against BD Lutonix drug-coated balloon for below-the-knee

February 18, 2021 By Danielle Kirsh

BD-logoAn FDA advisory panel voted against a favorable recommendation for BD‘s Lutonix catheter-based, drug-coated balloon for use below the knee.

The FDA’s Circulatory System Devices Advisory Panel yesterday voted 15-to-2 in favor of the issue of safety when Lutonix is used as intended and voted 15-to-2 against the issue of a reasonable assurance of effectiveness. The panel also voted 14-to-3 against whether the benefits outweigh the risks. There was one abstained vote for each measure.

The Lutonix 014 Drug-Coated Balloon PTA catheter had a proposed indication for use for percutaneous transluminal angioplasties of obstructive de novo or non-stented restenotic lesions in popliteal, tibial and perineal arteries up to 320 mm in length. The advisory panel convened to provide input and recommendations to the FDA to support the agency’s review of Lutonix in the treatment of below-the-knee arteries in patients with critical limb ischemia.

Information presented during the panel meeting included six-month primary endpoint data and safety data out to 36 months from the Lutonix BTK IDE pivotal trial that enrolled 462 patients from the U.S., Europe, Canada and Japan in a multicenter, prospective, single-blind, randomized trial.

“While the panel’s vote on the question of safety was favorable, their votes on effectiveness and risk-benefit focused on study design and the challenges of executing a trial over eight years in this complex patient population,” said J.D. Meler, VP of medical affairs for BD’s peripheral intervention business.

“We thank FDA and the panel for the opportunity to bring these important data to light in this area of unmet need, and thank the clinicians, patients and advocates who shared their personal thoughts and experiences with the panel,” Meler said in a news release.

The FDA denied the Lutonix drug-coated balloon catheter’s approval for use below the knee in early 2019. At the time, the agency said that its preliminary review of long-term follow-up data found a “potentially concerning signal” of increased long-term mortality in people with peripheral artery disease who were treated with paclitaxel-coated devices compared to those treated with bare devices.

 

Filed Under: Catheters, Research & Development Tagged With: BD

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Tubing + Extrusion, Medical Design & Outsourcing and MassDevice. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS